LGALS9 and metabolic dysfunction-associated steatotic liver disease: Besides, serum level of Gal-9 or sTIM-3 could be the significant predictors for the presence of moderate-to-severe NAFLD, with odds ratio (OR) of 5.20 or 4.59, respectively.